Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRAISE: Autoimmunity in Cancer Immunotherapy
NCT03849131Phase 4Active, not recruiting
- Sponsor
- Strasbourg University Hospital
- Start
- Nov 2019
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 4, single-arm trial, sponsored by Strasbourg University Hospital. Primary endpoint: Incidence of severe autoimmune manifestations at 2 years. Started Nov 2019; status: active, not recruiting.
Beyond the preview
Go deeper on NCT03849131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03849131.